✦ LIBER ✦

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

✍ Scribed by Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, Hiroshi; Kobayashi, Yoshimitsu; Iwanaga, Ichiro; Nakamura, Michio; Hatanaka, Kazuteru; Miyagishima, Takuto; Kudo, Mineo; Munakata, Masaki; Meguro, Takashi; Tateyama, Miki; Sakata, Yuh

Book ID: 119964506
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 104 KB
Volume: 51
Category: Article
ISSN: 0284-186X
DOI: 10.3109/0284186X.2012.682629

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3053 POSTER Phase II study of combinatio

3053 POSTER Phase II study of combination with irinotecan and S-1 (IRIS) for inoperable recurrent advanced colorectal cancer (HGCSG0302). Safety analysis

✍ S. Yuki; Y. Komatsu; N. Machida; M. Ozasa; K. Nishi; T. Miyagishima; T. Kato; M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A phase II study of combination therapy

A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer

✍ Manabu Shiozawa; Makoto Akaike; Nobuhiro Sugano; Kazuhito Tsuchida; Naoto Yamamo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 347 KB

Phase I study of bevacizumab combined wi

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

✍ Hitoshi Kusaba, Taito Esaki, Junji Kishimoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 179 KB

6049 Phase II trial of combined chemothe

6049 Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer

✍ Hatanaka, K.; Komatsu, Y.; Yuki, S.; Nakamura, M.; Miyagishima, T.; Kudo, M.; Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase II study evaluating the feasibil

A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer

✍ Taishi Hata, Mutsumi Fukunaga, Kohei Murata… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 247 KB

Multicenter phase II study of second-lin

Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy

✍ Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh P 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB